InfraReDx Obtains $21,000,000 Series D Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f217aa6a-e129-4aab-8f43-93eec1c5d6ff&Preview=1 -
Date
10/12/2010 -
Company Name
InfraReDx -
Mailing Address
34 Third Avenue Burlington, MA 01803 -
Company Description
The company has now developed a fiber-optic, catheter-based, near infrared (NIR) spectroscopy system designed to characterize the composition of coronary plaques in patients undergoing catheterization. This NIR system is currently being evaluated in a clinical study. -
Website
http://www.infraredx.com -
Transaction Type
Venture Equity -
Transaction Amount
$21,000,000 -
Transaction Round
Series D -
Proceeds Purposes
Funds from the financing are being used to support the full commercial launch of the LipiScan IVUS Coronary Imaging System, the world’s first and only intravascular imaging system that combines and co-registers grayscale intravascular ultrasound (IVUS) with InfraReDx’s proprietary near infrared (NIR) spectroscopy lipid core plaque (LCP) detection technology. -
M&A Terms
-
Venture Investor
Sanderling Ventures -
Venture Investor
Undisclosed
